Skip to main content
OpenTrials
Completed

NCT Number: NCT00225511

Study Evaluating Effexor XR for Major Depression.

Study Evaluating Effexor XR for Major Depression.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression Behavior Behavioral Symptoms

Age range

20 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Nagoya, Aichi-ken, Japan

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with major depression based on DSM-IV-TR
  • Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" at the baseline.

Exclusion criteria

  • Patients with schizophrenia or any other psychotic disorder
  • Patients with history or presence of bipolar disorder

Treatment and study plan

Effexor XR

Drug

Milnacipran

Drug

Primary outcomes

  1. Response rate of HAM-D17 (Hamilton Rating Scale for Depression) at the final-on-therapy.

Secondary outcomes

  1. Difference of total score of HAM-D17 between baseline and final-on-therapy.

  2. Remission rate of HAM-D17 at the final-on-therapy.

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

Phase III Multi-Center, Double-Blind, Comparative Study of Effexor XR for the Treatment of Depression

Important dates

Study start
2004
First posted
Sep 23, 2005
Registry last updated
May 24, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.